Lv21
190 积分 2023-12-18 加入
Overcoming osimertinib resistance with AKT inhibition in EGFRm-driven Non-Small-Cell-Lung-Cancer with PIK3CA/PTEN alterations
29天前
已完结
PIKing up and AKTing on resistance mutations in osimertinib-treated EGFR-mutated NSCLC
29天前
已完结
Pharmacological management of antifungal agents in pulmonary aspergillosis: an updated review
11个月前
已完结
皖公网安备34019202002308
